Skip to NavigationSkip to content's weekly COVID-19 news round-up

Published on 09/04/20 at 12:39pm
Image credit: CDC

The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in development at British American Tobacco. Donald Trump continues to tout the effectiveness of hydroxychloroquine in treating the virus and threatens India after they shut down exports of the drug, and Martin Shkreli has asked to be furloughed from prison to help develop a treatment of his own.

1. British American Tobacco creating coronavirus vaccine Published 02/04/20

The owner of famous cigarette brands, such as Lucky Strike, Dunhill, Rothmans and Benson & Hedges, the company is using its biotech subsidiary Kentucky BioProcessing to work on developing a COVID-19  vaccine.

2. British Health Secretary says more patients with COVID-19 are needed for clinical trials Published on 06/04/20 

Matt Hancock, the UK’s Health Secretary, has said that more patients with the COVID-19 coronavirus are need in clinical trials testing licensed drugs that could be effective in treating the virus.

3. Donald Trump talks of “retaliation” if India does not export hydroxychloroquine to the US - Published on 07/04/20

United States President Donald Trump has suggested that the US may retaliate if India did not export the anti-malaria drug hydroxychloroquine, which is being used to treat COVID-19.

4. Martin Shkreli asks to be furloughed from prison to work on COVID-19 treatments Published on 07/04/20

Disgraced biotech entrepreneur Martin Shkreli, also known as the ‘Pharma Bro’, is asking for a brief furlough from prison to spend time working on a treatment for COVID-19.

5. Inovio’s coronavirus vaccine, funded by Bill Gates, begins human trials Published on 07/04/20

Inovio’s coronavirus vaccine has entered human trials after the FDA approved its application to begin them under the Investigational New Drug program. The research has been partly funded by The Bill and Melinda Gates Foundation.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches